Barclays Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,550.00

by · The Cerbat Gem

Mettler-Toledo International (NYSE:MTD – Free Report) had its price objective reduced by Barclays from $1,600.00 to $1,550.00 in a research note released on Monday,Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock.

MTD has been the topic of several other research reports. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 8th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday. Finally, JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $1,441.67.

Get Our Latest Research Report on MTD

Mettler-Toledo International Trading Down 0.1%

Shares of Mettler-Toledo International stock opened at $1,384.84 on Monday. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The company has a market cap of $28.29 billion, a P/E ratio of 34.53, a P/E/G ratio of 4.48 and a beta of 1.40. The stock has a 50-day moving average price of $1,406.27 and a 200 day moving average price of $1,297.87.

Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, equities analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 1,000 shares of the business’s stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the completion of the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,990,168. The trade was a 15.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elisha W. Finney sold 474 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director owned 311 shares of the company’s stock, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 19,565 shares of company stock valued at $28,683,737 in the last three months. 1.94% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Versant Capital Management Inc boosted its position in Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 8 shares during the period. SJS Investment Consulting Inc. lifted its stake in shares of Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after buying an additional 27 shares during the last quarter. WPG Advisers LLC bought a new stake in shares of Mettler-Toledo International during the 1st quarter worth $41,000. NewSquare Capital LLC grew its stake in Mettler-Toledo International by 94.4% in the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares during the last quarter. Finally, MV Capital Management Inc. grew its stake in Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories